Original Research

Published on 08 Apr 2024

Genetic prediction of causal association between serum bilirubin and hematologic malignancies: a two-sample Mendelian randomized and bioinformatics study

in Hematologic Malignancies

Lihua Lu
Luting Luo
Xiang Li
Wanying Liu
Boheng Wu
Qing Cai
Jiazheng Li
Yan Huang
Yanxin Chen
Yongzhi Zheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1364834

1,449 views

Mini Review

Published on 04 Apr 2024

Competing risks data in clinical oncology

in Hematologic Malignancies

Haesook Teresa Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1360266

1,084 views
1 citation

Mini Review

Published on 03 Apr 2024

Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications

in Hematologic Malignancies

Mariusz A. Wasik
Patricia M. Kim
Reza Nejati

Frontiers in Oncology

doi 10.3389/fonc.2024.1383741

984 views
1 citation

Original Research

Published on 03 Apr 2024

IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia

in Hematologic Malignancies

Joaquin Garcia-Solorio
Juan Carlos Núñez-Enriquez
Marco Jiménez-Olivares
Janet Flores-Lujano
Fernanda Flores-Espino
Carolina Molina-Garay
Alejandra Cervera
Diana Casique-Aguirre
José Gabriel Peñaloza-Gonzalez
Ma. Del Rocío Baños-Lara

Frontiers in Oncology

doi 10.3389/fonc.2024.1337954

2,926 views

Original Research

Published on 03 Apr 2024

Analysis of the treatment and prognosis of 266 cases of extranodal natural killer/T-cell lymphoma, nasal type in a single medical center

in Hematologic Malignancies

Lei Yang
Liqiang Wei
Xin Li
Jia Cong
Jin Ye
Na Yao
Jing Yang
Liang Wang
Jingwen Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1388564

1,020 views

Review

Published on 02 Apr 2024

Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches

in Hematologic Malignancies

Claudia Bozzini
Fabiana Busti
Giacomo Marchi
Alice Vianello
Claudio Cerchione
Giovanni Martinelli
Domenico Girelli

Frontiers in Oncology

doi 10.3389/fonc.2024.1380358

2,410 views
3 citations

Original Research

Published on 28 Mar 2024

CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression

in Hematologic Malignancies

Cristiana Rodrigues
Paula Laranjeira
Aryane Pinho
Isabel Silva
Sandra Silva
Margarida Coucelo
Ana Catarina Oliveira
Ana Teresa Simões
Inês Damásio
Helena Matos Silva

Frontiers in Oncology

doi 10.3389/fonc.2024.1380648

2,296 views
3 citations

Review

Published on 27 Mar 2024

Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy

in Hematologic Malignancies

Charlotte F. M. Hughes
Gunjan L. Shah
Barry A. Paul

Frontiers in Oncology

doi 10.3389/fonc.2024.1373548

2,974 views

Systematic Review

Published on 26 Mar 2024

Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis

in Hematologic Malignancies

Jingkui Zhu
Jixin Fan
Tiantian Xie
Haiqiu Zhao
Runqing Lu
Yinyin Zhang
Yingmei Li
Xinsheng Xie
Dingming Wan
Zhongxing Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1361988

1,836 views

Original Research

Published on 26 Mar 2024

Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment

in Hematologic Malignancies

Cong Cheng
Dao-Xing Deng
Xiao-Hui Zhang
Lan-Ping Xu
Yu Wang
Chen-Hua Yan
Huan Chen
Yu-Hong Chen
Wei Han
Feng-Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390438

944 views

Case Report

Published on 25 Mar 2024

A case report of atypical chronic myeloid leukemia with complete hematological and major molecular response to Venetoclax/Azacitidine treatment

in Hematologic Malignancies

Hongxia Chen
Ning Wang
Yin Li
Xiaohong Xie
Yi Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1327834

1,131 views

Original Research

Published on 22 Mar 2024

TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non-invasive diagnostic model

in Hematologic Malignancies

Zhenhao Wang
Yu Mei
Zhuming Yang
Qiang Gao
Hao Xu
Zhiqiang Han
Zhenya Hong

Frontiers in Oncology

doi 10.3389/fonc.2024.1369346

1,281 views

Review

Published on 22 Mar 2024

Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma

in Hematologic Malignancies

Catarina Geraldes
Adriana Roque
Ana Bela Sarmento-Ribeiro
Manuel Neves
Alina Ionita
Rita Gerivaz
Ana Tomé
Sofia Afonso
Maria Pedro Silveira
Patrícia Sousa

Frontiers in Oncology

doi 10.3389/fonc.2024.1282300

2,959 views
2 citations

Original Research

Published on 21 Mar 2024

CD7-positive leukemic blasts with DNMT3A mutations predict poor prognosis in patients with acute myeloid leukemia

in Hematologic Malignancies

Yanliang Bai
Xiaobai Sun
Mengyi Li
Xiaona Niu
Weijie Cao
Junwei Niu
Xingjun Xiao
Yuqing Chen
Kai Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1342998

1,755 views

Review

Published on 21 Mar 2024

A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL

in Hematologic Malignancies

Ruah Alyamany
Riad El Fakih
Ahmed Alnughmush
Abdulwahab Albabtain
Mohamed A. Kharfan-Dabaja
Mahmoud Aljurf

Frontiers in Oncology

doi 10.3389/fonc.2024.1301979

2,757 views

Original Research

Published on 20 Mar 2024

NUP214 fusion genes in acute leukemias: genetic characterization of rare cases

in Hematologic Malignancies

Marta Brunetti
Kristin Andersen
Signe Spetalen
Andrea Lenartova
Liv Toril Nygård Osnes
Helen Vålerhaugen
Sverre Heim
Francesca Micci

Frontiers in Oncology

doi 10.3389/fonc.2024.1371980

1,441 views

Navigation group

Articles

Genetic prediction of causal association between serum bilirubin and hematologic malignancies: a two-sample Mendelian randomized and bioinformatics study

Competing risks data in clinical oncology

Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications

IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia

Analysis of the treatment and prognosis of 266 cases of extranodal natural killer/T-cell lymphoma, nasal type in a single medical center

Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches

CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression

Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy

Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis

Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment

A case report of atypical chronic myeloid leukemia with complete hematological and major molecular response to Venetoclax/Azacitidine treatment

TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non-invasive diagnostic model

Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma

CD7-positive leukemic blasts with DNMT3A mutations predict poor prognosis in patients with acute myeloid leukemia

A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL

NUP214 fusion genes in acute leukemias: genetic characterization of rare cases